Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $946000.0.

  • Bioharvest Sciences' Accumulated Expenses rose 38020.3% to $946000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $946000.0, marking a year-over-year increase of 38020.3%. This contributed to the annual value of $401000.0 for FY2024, which is 1244.54% down from last year.
  • As of Q3 2025, Bioharvest Sciences' Accumulated Expenses stood at $946000.0, which was up 38020.3% from $463000.0 recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' Accumulated Expenses peaked at $946000.0 during Q3 2025, and registered a low of $197000.0 during Q3 2024.
  • Its 3-year average for Accumulated Expenses is $427375.0, with a median of $401000.0 in 2024.
  • Examining YoY changes over the last 5 years, Bioharvest Sciences' Accumulated Expenses showed a top increase of 38020.3% in 2025 and a maximum decrease of 4588.53% in 2025.
  • Bioharvest Sciences' Accumulated Expenses (Quarter) stood at $458000.0 in 2023, then fell by 12.45% to $401000.0 in 2024, then soared by 135.91% to $946000.0 in 2025.
  • Its Accumulated Expenses was $946000.0 in Q3 2025, compared to $463000.0 in Q2 2025 and $217000.0 in Q1 2025.